Egberts, Karin
Reuter-Dang, Su-Yin
Fekete, Stefanie
Kulpok, Christine
Mehler-Wex, Claudia
Wewetzer, Christoph
Karwautz, Andreas
Mitterer, Michaela
Holtkamp, Kristian
Boege, Isabel
Burger, Rainer
Romanos, Marcel
Gerlach, Manfred
Taurines, Regina https://orcid.org/0000-0002-8704-1424
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (001EZ0937)
Verein zur Durchführung Neurowissenschaftlicher Veranstaltungen e.V.
Innovation Committee of the German Federal Joint Committee (01NVF16021)
German Federal Institute for Drugs and Medical Devices (73.05/3832-397285/12)
Article History
Received: 31 May 2020
Accepted: 10 September 2020
First Online: 30 September 2020
Compliance with ethical standards
:
: MR currently receives a research grant from Kids-Safe (Innovation Committee of the German Federal Joint Committee (G-BA), grant number 01NVF16021). KE, RT, MR, MG received grant research support from the German Federal Institute for Drugs and Medical Devices (BfArM- reference number: 73.05/3832–397285/12). IB, RB, KE, SF, MG, KH, AK, CK, CM, MM, MR, SR, RT, CW report no (further) conflict of interest.
: The study was approved by the ethics committee of the University Hospital of Wuerzburg (study number 27/04).
: There was no need for written informed consent for the measurement of the aripiprazole serum concentration as this was part of the routine clinical care for the included patients.
: The manuscript is not being considered for publication elsewhere and we understand that if accepted for publication by the <i>Journal of Neural Transmission</i>, copyright will be assigned to the publisher.
: The data that support the findings of this study are available from the corresponding author, RT, upon reasonable request<b>.</b>